In Chronic Obstructive Pulmonary Disease (COPD), hypermethylation of the NRF2 promoter leads to decreased NRF2 expression in the lungs of patients, resulting in the inhibition of the NRF2-GPX4 axis and subsequent induction of ferroptosis. Here, GPX4 is linked to chronic obstructive pulmonary disease.